Board of Directors


Anders Tullgren
Chairman of the Board

Anders Tullgren is Chairman of Trialbee AB, Sweden and Board member of BrandingScience Ltd, UK. He has over 30 years of global experience in the pharmaceutical industry and has had senior leadership roles in the United States, Germany, France, the United Kingdom and the Nordic region. The latest role he left in 2017 was as President of the Interkontintala region of Bristol Myers Squibb with responsibility for over 30 countries, 5,000 employees and a turnover of over 20 billion. He holds a MSc in Pharmacy from Uppsala University.

Saeid Esmaeilzadeh DSC_4068-Redigera-4

Board Member

Saeid is a serial entrepreneur having established and managed a range of research-intensive companies in various industries. In 2002 he became the youngest associate professor in Sweden. He has received many distinctions and awards for his research as well as for his achievements as an entrepreneur. Saeid is an experienced board member and since 2010 has been the CEO of Serendipity Innovations. Saeid has a Ph.D. in Materials Chemistry from Stockholm University.

Maris hartmanis_small

Board Member

Maris is a seasoned industrial executive and leader with almost 30 years of CEO, senior R&D management and Board of Director experience from the international Life Science area. His experience stems from large organizations, as well as entrepreneurial start-ups. Most recently he was the CEO of two Swedish public pharmaceutical companies. Maris has a Ph.D. degree in Biochemistry from the Royal Institute of Technology in Stockholm, where he also is an Associate Professor.


Board Member

Karin has a broad experience of the international pharmaceutical industry from senior positions within regulatory, pharmaceutical and analytical R&D, project leadership as well as clinical. Most recently Karin held the position of Global Head and Vice President of Clinical Development at AstraZeneca.


Board Member

Professor Peter Edman has an extensive experience in drug development from the pharmaceutical industry and has held a number of senior research leadership positions within Orexo, Sobi, Biovitrum, AstraZeneca, Astra and Pharmacia. He has also held a position as Associate Professor at the Swedish Medical Product Agency. In addition, Peter has been Professor in Pharmaceutical Formulation and Adjunct Professor in Drug Delivery at the Faculty of Pharmacy, University of Uppsala.


Board Member

Giorgio is educated in finance and business administration at the University Luigi Bocconi in Italy and operates as Head of Mergers & Acquisitions at UBI Banca SpA. Giorgio also has a board assignment for Axxam SpA.


Board Member

Alessandro is educated in biology at Pavia University in Italy and operates as CEO of Axxam SpA. Alessandro also has board assignments for FEDERCHIMICA, Italian Association of Business Angels, ALISEI and Externautics SpA.


Remuneration committee

The following board members are members of the Remuneration committee:
Saeid Esmaeilzadeh
Maris Hartmanis
Giorgio Chirivi

Transaction committee

The following board members are members of the Transaction committee:
Saeid Esmaeilzadeh
Peter Edman
Alessandro Sidoli

Audit committee

The following board members are members of the Audit committee:
Giorgio Chirivi
Karin Wingstrand